Injective INJ
Current Price
$3.89 +0.93%
$0.1200 Daily Range (3.08%)
$3.80$3.92
$58.02M Daily Volume
716 BTC
Vol/MktCap: 14.92%
Market Performance
0.14% Relative BTC Volume
The total volume of Injective is $58.02M over the past 24 hours, compared to $41.25B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.87 +0.54%
13 SMA $3.87 +0.46%
21 SMA $3.87 +0.42%
55 SMA $3.79 +2.54%
144 SMA $3.74 +4.00%
Price Performance
-0.02% 1 Hour Change
$3.89 from $3.89
+12.94% 7 Day Change
$0.5032 from $3.39
+19.37% 14 Day Change
$0.7536 from $3.14
+36.80% 30 Day Change
$1.43 from $2.46
All Time High
March 14, 2024
$52.62 -92.61%
-$48.73 vs. now
24H Change
3.64M USD +0.95%
45 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
4.99 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
15.03M INJ
traded over past 24 hours
15.03% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $3.90, experiencing a 24-hour change of 2.58%. The daily trading range has been tight, with a high of $3.92 and a low of $3.75, indicating relatively stable price action within this period.
The trading volume stands at approximately 60.08 million, representing a volume-to-market cap ratio of 15.40%. This level of volume suggests a healthy trading environment, reflecting investor interest and engagement with INJ, which can support further price movements.
The hourly moving averages indicate a bullish trend, with the 8 SMA and 13 SMA both showing an increase of 0.58% at $3.88. Additionally, the longer-term moving averages, such as the 55 SMA and 144 SMA, demonstrate stronger gains of 3.30% and 4.79%, respectively, reinforcing the upward momentum.
The 1-hour RSI is at 57, suggesting that INJ is nearing overbought territory but still has room for further upward movement. Meanwhile, the 7-day and 14-day RSIs are at 58 and 17.45% price change, respectively, indicating sustained bullish sentiment over the short to medium term.
Over the past 30 days, INJ has increased by approximately 33.92%, showcasing strong performance and suggesting that market participants are confident in its continued growth potential. However, it remains significantly below its all-time high of $52.62 reached in March 2024, indicating substantial room for recovery.
Given the current technical indicators, bullish moving averages, and sustained upward price trends, the outlook for Injective (INJ) appears positive. Therefore, a Buy rating is warranted as the asset shows strong momentum and potential for further gains in the near term.
The trading volume stands at approximately 60.08 million, representing a volume-to-market cap ratio of 15.40%. This level of volume suggests a healthy trading environment, reflecting investor interest and engagement with INJ, which can support further price movements.
The hourly moving averages indicate a bullish trend, with the 8 SMA and 13 SMA both showing an increase of 0.58% at $3.88. Additionally, the longer-term moving averages, such as the 55 SMA and 144 SMA, demonstrate stronger gains of 3.30% and 4.79%, respectively, reinforcing the upward momentum.
The 1-hour RSI is at 57, suggesting that INJ is nearing overbought territory but still has room for further upward movement. Meanwhile, the 7-day and 14-day RSIs are at 58 and 17.45% price change, respectively, indicating sustained bullish sentiment over the short to medium term.
Over the past 30 days, INJ has increased by approximately 33.92%, showcasing strong performance and suggesting that market participants are confident in its continued growth potential. However, it remains significantly below its all-time high of $52.62 reached in March 2024, indicating substantial room for recovery.
Given the current technical indicators, bullish moving averages, and sustained upward price trends, the outlook for Injective (INJ) appears positive. Therefore, a Buy rating is warranted as the asset shows strong momentum and potential for further gains in the near term.
Updated 451 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Grant Cardone says bitcoin-real estate strategy could outperform REITs, adds more BTC to treasury
The real-estate mogul said the hybrid model brings new users into crypto and challenges traditional real estate structures.

Bittrex Wants Its $24 Million Settlement Back, Now That the SEC Is Pro-Crypto
Now-shuttered crypto exchange Bittrex settled with the SEC back in 2023 after being accused of offering illegally unregistered securities.

dogwifhat: WIF jumps 44%, breaks April’s $0.225 high on Upbit news
How WIF price broke a key resistance level after listing on Upbit.

This AI Reads Your Chemistry Instructions and Finds the Best Way to Build You a Molecule
Researchers at EPFL built a framework that lets chemists describe what they want in plain language—and have AI sift through thousands of synthesis routes to find the right one.